Latest Breaking News On - Tonix pharmaceutical - Page 8 : comparemela.com

Research and Development Moves the Psychedelics Market Forward - FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Jan. 27, 2021 /PRNewswire/ The ongoing surge of development and investment into psychedelic medicine and psychedelic-assisted therapy is the direct result of newfound public support and legitimacy for these revolutionary treatments. That legitimacy is being built on the back of a growing body of research showing the benefits of these treatments and the intense need for alternatives to legacy approaches to mental healthcare. The flood of research is continuing, most recently with an ongoing study on psychosubstances as a potential treatment for veterans with PTSD. As more data supports the legitimacy of these treatments, companies that are commercializing psychedelic medicines, like

Kostenloser wertpapierhandelRakesh jetlyJoshua bartchOrbitrap explorisUniversity of albertaTonix pharmaceuticalsFn media groupMydecine innovations groupMydecine coHollister biosciences incNational psychotrauma centreMydecine innovations group incNuminus wellness incBiotechnology companies work to advance psychedelic therapeuticsExchange commissionLeiden university medical center